🩸🔍 Today’s questions!
Swipe to see the answers and explanations!
#SmolderingMultipleMyeloma #SMM #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #HemeHub
@hemehub.bsky.social
@hemehub.bsky.social🩸🔍 Today’s questions!
Swipe to see the answers and explanations!
#SmolderingMultipleMyeloma #SMM #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #HemeHub
@hemehub.bsky.social💭🎯 Today’s questions!
Swipe to see the answers and explanations!
#SmolderingMultipleMyeloma #SMM #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #MRD #ASCT #StemCellTransplant #APOBEC #HemeHub
@societyofhemonc.bsky.socialTelomere biology disorders linked to substantial morbidity and frequent clonal hematopoiesis
Data presented at #SOHO2026 by Dr. Olisaemeka Ogbue of @MayoClinic. #HemeOnc #BloodCancer
@hemehub.bsky.social💡🚀 Today’s questions!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #HemeHub
@hemehub.bsky.social🧬 Facts about Smoldering Multiple Myeloma:
Genomic drivers of progression, APOBEC and AID activity, genomic risk scoring, and MAF/MAFB translocations.
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #HemeHub
@hemehub.bsky.social🌟📣 The HemeHub Hematology Summit is almost here!
🗓️ October 3, 2026
📍 Gaylord Texan Resort & Convention Center
Registration is filling quickly. Secure your spot today!
Register: hemehub.org/events/hemeh...
#HemeHub #HemeOnc #Hematology #HematologySummit #MedicalEducation #Oncology
@bloodpac.bsky.social📅 Save the date! Join BLOODPAC's New Frontiers Seminar: Molecular Residual Disease in Hematologic Cancers: Progress, Challenges, and Future Directions
🗓 Dec. 9, 2026
⏰ 1–3 PM ET
💻 Virtual
@hemehub.bsky.social🌟🔎Today’s questions!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #Immunology #MedicalEducation #MedEd #ClinicalHematology #HemeHub
@hemehub.bsky.social🩸 Facts about Smoldering Multiple Myeloma:
The PANGEA risk model, key progression biomarkers, limitations of static risk models, and progression risk across low-, intermediate-, and high-risk SMM.
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub
@hemehub.bsky.social🎯Today’s questions!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #Genomics #HemeHub
@hemehub.bsky.social🩸 Facts about Smoldering Multiple Myeloma:
Key SMM risk models include Mayo 2008, PETHEMA, IMWG 20/2/20, cytogenetic risk refinement, and the MGUS-like phenotype.
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub
@hemehub.bsky.social🌟 Registration for the HemeHub Hematology Summit is filling quickly!
🗓️ October 3, 2026
📍 Gaylord Texan Resort & Convention Center
Registration: hemehub.org/events/hemeh...
#HemeHub #HemeOnc #Hematology #HematologySummit #MedicalEducation #Oncology
@hemehub.bsky.social📢 Webinar Update
Our Smoldering Multiple Myeloma webinar with Shaji Kumar, MD and Adeel Khan, MD has been rescheduled following the passing of Robert A. Kyle, MD.
We extend our condolences to his family and the myeloma community.
Register: hemehub.org/live-webinars
@hemehub.bsky.social🚀💡Today’s questions!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #HemeHub #Daratumumab #AQUILA #CENTAURUS
@hemehub.bsky.social🩸 Facts about Smoldering Multiple Myeloma:
SLIM-CRAB criteria, precursor stages, immunoparesis, evolving biomarkers, and circulating tumor cells all play a role in assessing SMM progression risk.
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub
@jbmtct.bsky.socialThe refined 2023 European Society for Blood & Marrow Transplantation criteria enable earlier diagnosis of SOS/VOD (probable, clinical, proven categories), allowing faster initiation of defibrotide and leading to improved survival in HSCT patients. doi.org/10.46765/267...
#HemeOnc #HemeSky #JBMTCT
@hemehub.bsky.social🌟🎯First clinical questions of the month!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Myeloma #PlasmaCellDisorders #MGUS #IMWG #Hematology #HemeOnc #Oncology #ClinicalHematology #MedicalEducation #MedEd #HemeHub
@hemehub.bsky.social🩸📢 The links for the HemeHub Hematology Summit have been updated!
Registration: hemehub.org/events/hemeh...
Full program and event details:
hemehub.org/events/hemeh...
🗓️ October 3, 2026
📍 Gaylord Texan Resort & Convention Center
#HemeHub #HemeOnc #Myelofibrosis #MultipleMyeloma #CLL #PNH #DLBCL
@hemehub.bsky.social🌟 We’re honored to welcome Ayalew Tefferi, M.D., to the HemeHub Hematology Summit!
Dr. Tefferi is a Mayo Clinic hematology expert specializing in myeloproliferative neoplasms.
🎙️ Session Topic: Myelofibrosis
🔗 Register: hemehub.org/events/hemeh...
#HemeHub #HematologySummit #HemeOnc#Myelofibrosis
@hemehub.bsky.social🩸🌎 HemeHub’s recorded webinars on YouTube have reached viewers in 65 countries worldwide, including Belarus, Uganda, Georgia, Kazakhstan, and many more.
Thank you to our growing global community for joining us!
🌐 Learn more: hemehub.org
#HemeHub #Hematology #Oncology #MedEd #GlobalHealth #HemeOnc
